Fig. 2.

Estimated Cumulative proportion of participants with virologic failure (confirmed HIV-1 RNA ≥ 1000 Copies/mL At or after 24 weeks) at Weeks 24 and 96 by Number of Risk Factors for Virologic Failure a Participant Had. Bars Show Breakdown of Those With Versus Without New NRTI and/or PI Mutations. Risk Factors Were Age at Study Entry < 30 Years, HIV-1 RNA at Study Entry ≥ 10,000 Copies/mL, CD4 Count at Study Entry < 2000 Cells/mm³, Any NRTI Resistance Identified at Study Screening, and Duration of Prior ART at Study Entry < 10 Years